David Huang
Senior Director OBI Pharma, Inc.
Seminars
Wednesday 14th October 2026
Evaluating Enzymatic Conjugation Strategies to Improve Dual Payload ADC Therapeutic Index at the Discovery Stage
12:00 pm
- Employing innovative conjugation chemistry to deliver two distinct payloads to the antibody Fc region
- Optimizing conjugation process across DAR fine tuning and payload selection to reduce dual payload ADC aggregation and enhance developability while accelerating optimal drug candidate selection
- Showcasing impact of discovery-stage innovation to deliver ADC properties and differentiation potential to patients
